UBR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.743200E-01
Normal-vs-Stage2
4.364200E-01
Normal-vs-Stage3
3.672500E-02
Normal-vs-Stage4
7.906000E-01
Stage1-vs-Stage2
1.770410E-01
Stage1-vs-Stage3
3.078100E-02
Stage1-vs-Stage4
6.459800E-01
Stage2-vs-Stage3
2.340500E-03
Stage2-vs-Stage4
6.216000E-01
Stage3-vs-Stage4
1.666000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.974800E-01
Normal-vs-AfricanAmerican
8.803200E-01
Normal-vs-Asian
5.359200E-01
Caucasian-vs-AfricanAmerican
2.245400E-01
Caucasian-vs-Asian
7.785800E-01
AfricanAmerican-vs-Asian
3.400200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.761000E-01
Normal-vs-Female
6.163800E-01
Male-vs-Female
4.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.377000E-01
Normal-vs-Age(41-60Yrs)
8.399800E-01
Normal-vs-Age(61-80Yrs)
4.403000E-01
Normal-vs-Age(81-100Yrs)
2.816800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.152200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.269400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.802800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.046500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.858200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.775000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.161600E-01
Normal-vs-Daily Drinker
2.297800E-01
Normal-vs-Weekly Drinker
2.063200E-01
Normal-vs-Occasional Drinker
9.696400E-01
Normal-vs-Social Drinker
6.851000E-01
Non Drinker-vs-Daily Drinker
9.141200E-01
Non Drinker-vs-Weekly Drinker
9.767600E-01
Non Drinker-vs-Occasional Drinker
6.229700E-02
Non Drinker-vs-Social Drinker
2.591800E-01
Daily Drinker-vs-Weekly Drinker
9.059200E-01
Daily Drinker-vs-Occasional Drinker
5.168300E-02
Daily Drinker-vs-Social Drinker
2.727800E-01
Weekly Drinker-vs-Occasional Drinker
1.000650E-01
Weekly Drinker-vs-Social Drinker
3.595400E-01
Occasional Drinker-vs-Social Drinker
4.628600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.161900E-02
Normal-vs-Grade 2
1.220030E-02
Normal-vs-Grade 3
1.668390E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.727000E-01
Grade 1-vs-Grade 3
6.333200E-01
Grade 1-vs-Grade 4
7.161900E-02
Grade 2-vs-Grade 3
7.359000E-01
Grade 2-vs-Grade 4
1.220030E-02
Grade 3-vs-Grade 4
1.668390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.515000E-01
Normal-vs-NonDiabetic
4.527400E-01
Diabetic-vs-NonDiabetic
2.723200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.747230E-01
Normal-vs-NoPancreatitis
4.421000E-01
Pancreatitis-vs-NoPancreatitis
3.266800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.890600E-01
Normal-vs-N1
4.728200E-01
N0-vs-N1
9.918600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.391200E-01
Normal-vs-TP53-NonMutant
9.636600E-01
TP53-Mutant-vs-TP53-NonMutant
2.408000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
